New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel HealthierPRNewsWire • 06/20/25
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?Zacks Investment Research • 06/19/25
5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year24/7 Wall Street • 06/13/25
Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?Market Watch • 06/06/25
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, AbbottInvestors Business Daily • 05/28/25
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart SurgeryPRNewsWire • 05/27/25
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?Zacks Investment Research • 05/22/25
Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys24/7 Wall Street • 05/20/25
Abbott Reveals Positive Outcome From REFLECT Studies, Stock ClimbsZacks Investment Research • 05/19/25
Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 05/16/25
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with DiabetesPRNewsWire • 05/15/25
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?Zacks Investment Research • 05/07/25